Supernus Announces Orphan Drug Exclusivity for ONAPGO™ (apomorphine HCl)GlobeNewswire·Oct 21, 2026 at 11:45 PMSUPN-0.27%
Supernus Pharmaceuticals publishes update to financial calendarPUBT·Oct 19, 2026 at 12:42 PMSUPN-0.27%
Supernus Pharmaceuticals Holds Special Stockholder MeetingPUBT·Oct 15, 2026 at 08:12 PMINDV+0.09%SUPN-0.27%
Supernus Pharmaceuticals (NASDAQ:SUPN) Hits New 12-Month Low - Here's What HappenedMarket Beat·Oct 14, 2026 at 08:20 PMSUPN-0.27%
How Investors May Respond To Supernus Pharmaceuticals (SUPN) FDA Approval For ONAPGOSimplywall·Oct 11, 2026 at 11:07 AMSUPN-0.27%
Indivior to rename as Supernus after merger; supplemental proxy discloses Cantor valuation rangesTradingView·Oct 6, 2026 at 11:23 AMINDV+0.09%SUPN-0.27%
Indivior Pharmaceuticals announces special shareholder meeting on merger with SupernusPUBT·Oct 6, 2026 at 11:16 AMINDV+0.09%SUPN-0.27%
Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?prnewswire·Sep 29, 2026 at 05:53 PMFHB+2.19%INDV+0.09%
ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTHprnewswire·Sep 28, 2026 at 11:23 PMFHB+2.19%INDV+0.09%
Are ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders?prnewswire·Sep 25, 2026 at 11:40 AMSUPN-0.27%ITGR-0.07%
Indivior Announces Special Dividend Ahead of Supernus MergerTip Ranks·Sep 17, 2026 at 11:47 AMINDV+0.09%SUPN-0.27%
Indivior sets USD 8.13 special dividend tied to Supernus merger closingPUBT·Sep 17, 2026 at 11:01 AMINDV+0.09%SUPN-0.27%
Novartis, GSK and more shine at Fierce Pharma Marketing AwardsFiercepharma·Sep 16, 2026 at 05:43 AMUCBJY+21.12%NVS+1.46%
Supernus Pharmaceuticals (SUPN) Just Drew Fresh Attention, What Is The Market Weighing?Simplywall·Sep 12, 2026 at 08:21 PMSUPN-0.27%
